# US 2025/0166780 A1 · Glycemic urgency assessment and alerts interface

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0166780 A1
- Document ID: US20250166780A1
- Status: Published application
- Kind: A1
- Application number: 19/029,581
- Filed: 2025-01-17
- Published: 2025-05-22
- Earliest claimed: 2014-04-10
- Assignees: DexCom, Inc.
- Applicants: Dexcom, Inc.
- Inventors: Anna Leigh Davis; Hari Hampapuram; Apurv Ullas Kamath; Eli Reihman; Leif N. Bowman; Arturo Garcia; Katherine Yerre Koehler; Naresh C. Bhavaraju; Rian Draeger; Paul Kramer; Paul Noble-Campbell
- Web page: https://patentgrep.com/patent/US20250166780A1

## CPC

- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/1112: {Global tracking of patients, e.g. by using GPS}
- A61B 5/1118: {Determining activity level}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/165: {Evaluating the state of mind, e.g. depression, anxiety}
- A61B 5/168: {Evaluating attention deficit, hyperactivity}
- A61B 5/4306: {for evaluating the female reproductive systems, e.g. gynaecological evaluations}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/4866: {Evaluating metabolism (using breath test A61B5/083)}
- A61B 5/6898: {Portable consumer electronic devices, e.g. music players, telephones, tablet computers}
- A61B 5/7239: {using differentiation including higher order derivatives}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61B 5/7405: {using sound}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- A61B 5/743: {Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots}
- A61B 5/7435: {Displaying user selection data, e.g. icons in a graphical user interface}
- A61B 5/746: {Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms}
- A61B 5/7475: {User input or interface means, e.g. keyboard, pointing device, joystick}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61M 5/5086: {for indicating if defective, used, tampered with or unsterile}
- G06F 3/04817: using icons (graphical or visual programming using iconic symbols G06F8/34)
- G06F 3/04847: Interaction techniques to control parameter settings, e.g. interaction with sliders or dials
- G16H 20/60: relating to nutrition control, e.g. diets
- G16H 40/63: for local operation
- A61B 2505/07: Home care
- A61B 2560/0295: adapted for recording user messages or annotations
- A61B 2560/0475: Special features of memory means, e.g. removable memory cards
- A61M 2005/1726: {the body parameters being measured at, or proximate to, the infusion site}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)

## Abstract

Systems and methods are disclosed that employ several or numerous factors in the determination of a glycemic urgency index (GUI), which may be based on a measured blood glucose level as well as other factors. The other factors may include time derivatives of the glucose level and/or other factors, e.g., user-entered data, data measured by other sensors or received from a network source, or historical data. The GUI is then presented to the user in an interesting way, e.g., via a background color or other inconspicuous notifier, e.g., on a mobile device such as a smart phone. The GUI may also be employed in the triggering of actionable alerts and alarms on an electronic device for the user. The GUI, or another index calculated from combinations of the variables and parameters described, may further be employed to drive a medicament delivery device such as a pump.

## Claims

### Claim 1

A method of assessing a user's urgency state associated with a physiological condition, comprising:
a. receiving data of a first type associated with a physiological condition;
b. calculating data of a second type associated with the physiological condition;
c. receiving data of a third type associated with the physiological condition;
d. determining an urgency index based at least on the received data of the first, second, and third types; and
e. providing an indication of the determined urgency index on a mobile device.

### Claim 2 (depends on 1)

The method of claim 1, wherein the physiological condition is diabetes, the urgency index is a glycemic urgency index, and the data of the first type is a glucose concentration.

### Claim 3 (depends on 2)

The method of claim 2, wherein the glucose concentration is a current measured glucose concentration, a past measured glucose concentration, or a future predicted glucose concentration.

### Claim 4 (depends on 1)

The method of claim 1, wherein the data of the second type is derived from the data of the first type.

### Claim 5 (depends on 4)

The method of claim 4, wherein the data of the second type derived from the data of the first type is a first derivative or a second derivative with respect to time of the data of the first type.

### Claim 6 (depends on 4)

The method of claim 4, wherein the data of the second type derived from the data of the first type includes: deviations from normal glucose patterns, pattern data of glucose values over a time period, predicted glucose values, a duration over which a glucose value is within a predetermined range, weightings of parameters or variables to be considered in the determining of the urgency index, or local maxima or minima in the data of the first type.

### Claim 7 (depends on 1)

The method of claim 1, wherein the receiving data of a third type includes receiving data entered by a user.

### Claim 8 (depends on 7)

The method of claim 7, wherein the receiving includes receiving data entered by a user on a user interface of a mobile device.

### Claim 9 (depends on 7)

The method of claim 7, wherein the physiological condition is diabetes, the urgency index is a glycemic urgency index, and the data of the first type is a glucose concentration, wherein the received data entered by a user includes a user weight, a user indication of activity level, a user indication of food or drink ingested or to be ingested, anthropometric data, data about prior insulin provided to the user, stress data, health data, data about a placement of the sensor measuring the data of the first type, age, or gender.

### Claim 10 (depends on 7)

The method of claim 7, wherein the received data entered by a user includes a user indication of food or drink ingested or to be ingested, or data about prior insulin provided to the user or to be provided to the user, and further comprising determining the glycemic urgency index to be a lower urgency based on the received data.

### Claim 11 (depends on 1)

The method of claim 1, wherein the receiving data of a third type includes receiving data from a sensor.

### Claim 12 (depends on 11)

The method of claim 11, wherein the physiological condition is diabetes, the urgency index is a glycemic urgency index and the data of the first type is a glucose concentration, and wherein the sensor includes at least one of the following: a scale, a glucometer, a thermometer, an accelerometer, a camera, a GPS device, or a microphone.

### Claim 13 (depends on 12)

The method of claim 12, wherein the received data of a third type includes a user weight, a user indication of activity level, an indication of food or drink ingested or to be ingested, anthropometric data, data about prior insulin provided to the user, physiological data, stress data, or health data.

### Claim 14 (depends on 1)

The method of claim 1, wherein the receiving data of a third type includes receiving data from a query processing engine, an electronic device configured for machine to machine communication, or an electronic user record.

### Claim 15 (depends on 1)

The method of claim 1, wherein the data of the third type is received from the mobile device, and corresponds to a level of user interaction with an application through which the indication was provided.

### Claim 16 (depends on 1)

The method of claim 1, further comprising providing an alert or alarm if the urgency index reaches a predetermined alerting or alarming threshold, respectively.

### Claim 17 (depends on 16)

The method of claim 16, wherein the urgency index is a glycemic index and the predetermined alerting or alarming threshold indicates that the user is in a hypoglycemic or hyperglycemic state.

### Claim 18 (depends on 1)

The method of claim 1, wherein the physiological condition comprises one or more of obesity, malnutrition, hyperactivity, depression, or fertility.

### Claim 19 (depends on 1)

The method of claim 1, further comprising providing an advanced output based on the received inputs.

### Claim 20

An electronic device for monitoring data associated with a physiological condition, comprising:
a. a continuous analyte sensor, wherein the continuous analyte sensor is configured to substantially continuously measure a concentration of analyte in the host, and to provide continuous sensor data associated with the analyte concentration in the host; and
b. a processor module configured to receive data of a first type associated with a physiological condition; calculate data of a second type associated with the physiological condition; receive data of a third type associated with the physiological condition; determine an urgency index based at least on the received data of the first, second, and third types; and provide an indication of the determined urgency index on a mobile device.
